1-7 of 7
Joachim Fruebis
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

BIVV001: The First Investigational Factor VIII Therapy to Break Through the VWF Ceiling in Hemophilia A, with Potential for Extended Protection for One Week or Longer

Barbara A Konkle, Amy Shapiro, Doris Quon, Janice Staber, Takashi Suzuki, MD PhD, Stacey Poloskey, Kara Rice, Suresh Katragadda, Dan Rudin, Joachim Fruebis
Journal: Blood
Blood (2018) 132 (Supplement 1): 636.
https://doi.org/10.1182/blood-2018-99-113575
Published: 2018
Journal Articles

PDE-9 Inhibition Combined with Hydroxyurea Is Beneficial in Vaso-Occlusive Crisis in Mouse Model of Sickle Cell Disease

Reema Jasuja, Sunita Patel Hett, Joachim Fruebis, PhD, Debra Pittman
Journal: Blood
Blood (2014) 124 (21): 2694.
https://doi.org/10.1182/blood.V124.21.2694.2694
Published: 2014
Journal Articles

A Zymogen-like Factor Xa Improves Hemostasis in a Murine Bleeding Model

Jasuja Reema, PhD, Sunita Patel-Hett, PhD, Rodney M. Camire, PhD, Joachim Fruebis, PhD, Debra Pittman
Journal: Blood
Blood (2014) 124 (21): 1476.
https://doi.org/10.1182/blood.V124.21.1476.1476
Published: 2014
Journal Articles

Zymogen-like FXa Is a Potent Bypassing Agent for Reversal of Direct FXa Inhibitors in Vivo

Nabil K. Thalji, BS, Lacramioara Ivanciu, PhD, Reema Jasuja, Sunita Patel-Hett, PhD, Joachim Fruebis, PhD, Debra Pittman, Rodney M. Camire, PhD
Journal: Blood
Blood (2014) 124 (21): 582.
https://doi.org/10.1182/blood.V124.21.582.582
Published: 2014
Journal Articles

Zymogen-Like FXa Is An Effective Pro-Hemostatic To Reverse The Anticoagulant Effects Of Direct FXa Inhibitors

Nabil K Thalji, BS, Sunita Patel-Hett, PhD, Reema Jasuja, PhD, Joachim Fruebis, PhD, Debra Pittman, MS, Rodney M. Camire, PhD
Journal: Blood
Blood (2013) 122 (21): 2383.
https://doi.org/10.1182/blood.V122.21.2383.2383
Published: 2013
Journal Articles

A Novel FVIIa Variant with Increased Potency and Duration of Effect Compared to Wildtype FVIIa. A Study in a Dog Model of Hemophilia A

Debra Pittman, MS, Stacey Weston, PhD, Kathleen Shields, BSc, Chuenlei Parng, PhD, Steven Arkin, MD, Ed Madison, PhD, Timothy C. Nichols, MD, Joachim Fruebis, PhD
Journal: Blood
Blood (2011) 118 (21): 2252.
https://doi.org/10.1182/blood.V118.21.2252.2252
Published: 2011
Journal Articles

C1qTNF–related protein-1 (CTRP-1): a vascular wall protein that inhibits collagen-induced platelet aggregation by blocking VWF binding to collagen

Gerald Lasser, Prasenjit Guchhait, Jeff L. Ellsworth, Paul Sheppard, Ken Lewis, Paul Bishop, Miguel A. Cruz, Jose A. Lopez, Joachim Fruebis
Journal: Blood
Blood (2006) 107 (2): 423–430.
https://doi.org/10.1182/blood-2005-04-1425
Published: 2006
Includes: Multimedia, Supplemental data